tert-Butyl (3S,4S)-3-amino-4-methoxypiperidine-1-carboxylate

Catalog No. :
ACKIVR186
CAS No. :
1207853-84-6
Molecular Formula :
C11H22N2O3
Molecular Weight :
230.31

IUPAC Name:tert-butyl (3S,4S)-3-amino-4-methoxypiperidine-1-carboxylate

tert-Butyl (3S,4S)-3-amino-4-methoxypiperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$183.00Login to see priceIn stockInquiry
250mg95%$310.00Login to see priceIn stockInquiry
1g95%$813.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (3S,4S)-3-amino-4-methoxypiperidine-1-carboxylate
IUPAC Nametert-butyl (3S,4S)-3-amino-4-methoxypiperidine-1-carboxylate
MDL No.MFCD18072080
Molecular FormulaC11H22N2O3
Molecular Weight230.31
SMILESO=C(N1C[C@H](N)[C@@H](OC)CC1)OC(C)(C)C
InChI KeyUVHQBZOMYULIOZ-IUCAKERBSA-N
Synonym1207853-84-6 | tert-butyl (3S,4S)-3-amino-4-methoxypiperidine-1-carboxylate | SCHEMBL376676 | MFCD18072080 | CS-0184964 | CS-0368747 | (3S,4S)-1-Boc-3-amino-4-methoxypiperidine | P18957 | t-Butyl (3S,4S)-3-amino-4-methoxypiperidine-1-carboxylate | tert-Bu
CAS No.1207853-84-6
PubChem CID58303360

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACKIVR186 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKIVR186 route product structure diagram
    ACKIVR1861207853-84-6 In Stock
Inquiry

2. ACKIVR186 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKIVR186 route product structure diagram
    ACKIVR1861207853-84-6 In Stock
Inquiry

Comments (0)